Utilizing Genomically Targeted Molecular Data to Improve Patient-Specific Outcomes in Autism Spectrum Disorder
Molecular biology combined with genomics can be a powerful tool for developing potential intervention strategies for improving outcomes in children with autism spectrum disorders (ASD). Monogenic etiologies rarely cause autism. Instead, ASD is more frequently due to many polygenic contributing facto...
Main Authors: | Sharon Hausman-Cohen, William LaValley, Heather Way, Emily Gutierrez, Jordan Reeder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/4/2167 |
Similar Items
-
Targeting Shank3 deficiency and paresthesia in autism spectrum disorder: A brief review
by: Min Huang, et al.
Published: (2023-02-01) -
Prenatal Zinc Deficient Mice as a Model for Autism Spectrum Disorders
by: Ann Katrin Sauer, et al.
Published: (2022-05-01) -
Genomics as a Clinical Decision Support Tool: Successful Proof of Concept for Improved ASD Outcomes
by: Heather Way, et al.
Published: (2021-06-01) -
The Shank3-InsG3680(+/+) mouse model of autism spectrum disorder displays auditory avoidance in a novel behavioral test
by: Ana Margarida Gonçalves, et al.
Published: (2023-08-01) -
SHANK3 Antibody Validation: Differential Performance in Western Blotting, Immunocyto- and Immunohistochemistry
by: Anne-Kathrin Lutz, et al.
Published: (2022-06-01)